Emcure Pharmaceuticals Ltd Quarterly Results

Q2 FY26-27 Results Summary

Revenue

The revenue stands at ₹2,820.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.30 per cent from ₹2,580.45 crore. This corresponds to a year-on-year *(YoY) growth of 24.26 per cent.

Operating Profit

Operating Profit stands at ₹587.84 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.39 per cent from ₹532.50 crore. This corresponds to a year-on-year *(YoY) growth of 23.63 per cent.

PBDT

PBDT stands at ₹555.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.43 per cent from ₹503.03 crore. This corresponds to a year-on-year *(YoY) growth of 24.54 per cent.

Profit Before Tax

Profit Before Tax stands at ₹445.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.30 per cent from ₹393.52 crore. This corresponds to a year-on-year *(YoY) growth of 30.59 per cent.

Net Profit

Net Profit stands at ₹325.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.14 per cent from ₹292.49 crore. This represents a 29.32 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Emcure Pharmaceuticals Ltd Earnings

CategoryQ2 FY26-27Q2 FY25-26Change %FY25-26FY24-25Change %
Total Revenue2,820.472,269.8224.269,203.547,896.0016.56
Expenses2,232.631,794.3424.437,370.346,432.0014.59
Other Income3.253.124.1712.6667.26-81.18
Operating Profit587.84475.4823.631,845.861,531.2620.55
Depreciation109.66104.644.80415.05384.138.05
Interest35.5832.549.34143.67175.78-18.27
Profit Before Tax445.86341.4230.591,287.14971.3532.51
Tax120.7990.0534.14392.56292.1634.36
Net Profit325.07251.3729.32941.27707.4733.05
CategoryQ2 FY26-27Q1 FY26-27Change %
Total Revenue2,820.472,580.459.30
Expenses2,232.632,047.959.02
Other Income3.252.0757.00
Operating Profit587.84532.5010.39
Depreciation109.66109.510.14
Interest35.5831.5412.81
Profit Before Tax445.86393.5213.30
Tax120.79101.0319.56
Net Profit325.07292.4911.14

Emcure Pharmaceuticals Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 1,695JM Financial25-Nov-2025

Emcure Pharmaceuticals Ltd Financial Reports

Data not available.

Emcure Pharmaceuticals Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Emcure Pharma0.86%0.65%34.08%26.18%34.46%73.59%
Anthem Bioscienc2.54%0.78%16.85%7.75%22.08%47.85%
Ipca Labs.0.48%-0.04%-2.65%-2.33%13.33%29.24%
Glaxosmi. Pharma3.35%2.49%10.20%-6.37%16.99%8.74%
Ajanta Pharma0.05%-2.51%0.47%-10.05%4.02%31.76%
Sai Life0.09%-0.45%28.50%23.04%57.50%108.02%
Wockhardt7.61%9.08%16.65%15.95%36.57%66.66%

Emcure Pharmaceuticals Ltd Corporate Information

Whole Time Director: MUKUND KESHAO GURJAR
CMD & CEO: SATISH RAMANLAL MEHTA
Whole-time Director: NAMITA VIKAS THAPAR
Whole Time Director & COO: SAMIT SATISH MEHTA
Independent Director: Vidya Rajiv Yeravdekar
Independent Director: Vijay Gokhale
Independent Director: Shailesh Ayyangar
Non Executive Director: Samonnoi Banerjee
Company Sec. & Compli. Officer: Amruta Jana Yangalwar
Additional Director: RAMAN PILLAI RAGHU KUMAR

Emcure Pharmaceuticals Ltd News

No More Data

More